actome

Actome is a Germany-based startup at the forefront of revolutionizing life science research and medical innovations with its proprietary Protein Interaction Coupling (PICO) technology. This groundbreaking technology allows for the quantification of proteins, protein interactions, and post-translational modifications in biological samples with unprecedented sensitivity and specificity, addressing the need for highly sensitive analysis of biomarkers in personalized healthcare and drug target interactions in research.

Actome not only provides assay kits but also offers a bioinformatics software as a service for result analysis, aiming to make the process more accessible and user-friendly. Moreover, the flexibility of their technology allows for the measurement of a large number of interactions simultaneously, using only minute amounts of biological samples, such as single cells.

Recognized for its innovative approach, Actome has received notable acclaim, including winning several business plan competition awards in 2019 and being listed among the top 50 startups in Germany in 2020. The company's momentum was further fueled by a recent Seed Round investment in December 19, 2022 led by The European Innovation Council. This injection of funds positions Actome for continued growth and impact in the Biopharma and Biotechnology industries.